Goldman Sachs Aktienanleihe RWE 2.../ DE000GG5HW17 /
| 8/6/2024 9:35:33 AM | Chg.+0.63 | Bid10:57:17 AM | Ask10:57:17 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 99.78EUR | +0.64% | 99.41 Bid Size: 200,000 |
99.61 Ask Size: 100,000 |
RWE AG INH O.N. | 31.00 - | 3/25/2026 | Call |
GlobeNewswire
6/25
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
6/18
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
6/12
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
6/11
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
6/5
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
6/4
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
5/23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
5/20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
5/13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
5/2
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
4/25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
